Abstract
Purpose. To gain information on the chemical stability pattern and the kinetics of the degradation of recombinant hirudin variant HVI (rHir), a thrombin-specific inhibitor protein of 65 amino acids, in aqueous solution as a function of pH.
Methods. Stability of rHir was monitored at 50°C in the framework of a classical pH-stability study in aqueous buffers pH 1−9.5. Two capillary electrophoresis (CE) protocols were used; one for the kinetics of succinimide formation at Asp53-Gly54 (C-terminal tail) and Asp33-Gly34 (loop section), the other for the kinetics of rHir degradation. To check for potential effects of conformational changes by thermal denaturation, circular dichroism (CD) measurements were performed between 25 and 80°C.
Results. Throughout the pH range studied no effect of thermal denaturation on rHir confirmation at 50°C was observed. rHir was most stable at a neutral pH whereas, at slightly acidic pH, an intermediate stability plateau was found. Both, strongly acidic and alkaline conditions led to fast rHir degradation. Depending on the pH of degradation, rHir was found to degrade in various combinations of multiple parallel and sequential degradation patterns. Special focus was on succinimide formation at Asp53-Gly54 (C-terminal tail) and Asp33-Gly34 (loop) and on the potential of isoAsp formation in position 53 and 33.
Conclusions. Chemical rHir stability in the intermediate pH range depends strongly on succinimide formation. At slightly acidic conditions succinimides represent the major degradation product (up to 40%). Around neutral pH succinimides react further, presumably by isoAsp formation, and concentrations remain low. Relative preference of succinimide formation in the C-terminal tail domain versus the loop domain is explained by higher backbone flexibility in the tail.
Similar content being viewed by others
REFERENCES
F. Markwardt. Untersuchungen über Hirudin. Naturwissenschaften 42:537–538 (1955).
W. E. Märki, H. Grossenbacher, M. G. Grütter, M. H. Liersch, B. Meyhack, and J. Heim. Recombinant hirudin: genetic engineering and structure analysis. Semin. Thromb. Hemostasis 17:88–93 (1991).
J.-Y. Chang. Stability of hirudin, a thrombin-specific inhibitor. J. Biol. Chem. 266(17):10839–43 (1991).
H. Grossenbacher, W. Märki, M. Coulot, D. Müller, and W. J. Richter. Characterization of succinimide-type dehydration products of recombinant hirudin variant 1 by electrospray tandem mass spectrometry. Rapid Communications in Mass Spectrometry 7:1082–1085 (1993).
S. Capasso, L. Mazzarella, F. Sica, A. Zagari, and S. Salvadori. Spontaneous cyclization of the aspartic acid side chain to the succinimide derivative. J. Chem. Soc. Chem. Commun. 919–921 (1992).
T. Geiger and St. Clarke. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. J. Biol. Chem. 262(2):785–794 (1987).
St. J. Wearne and T. E. Creighton. Effect of protein conformation on rate of deamidation: Ribonuclease A. Proteins 5:8–12 (1989).
M. Xie, D. V. Velde, M. Morton, R. T. Borchardt, and R. L. Schowen. pH-induced change in the rate-determining step for the hydrolysis of the Asp/Asn-derived cyclic-imide intermediate in protein degradation. J. Am. Chem. Soc. 118:8955–8956 (1996).
P. Schindler, D. Müller, W. Märki, H. Grossenbacher, and W. J. Richter. Characterization of a β-Asp33 isoform of recombinant hirudin sequence Variant 1 by low-energy collision-induced dissociation. J. Mass Spectrom. 24:967–974 (1996).
A. Tuong, M. Maftouh, C. Ponthus, O. Whitechurch, C. Roitsch, and C. Picard. Characterization of the deamidated forms of recombinant hirudin. Biochemistry 31:8291–8299 (1992).
A. P. Nordmann. Spectroscopic and related studies of recombinant hirudin, human neuropeptide Y and analogues, Ph.D. Thesis, Birkbeck College, London, 1996, p. 41.
S. J. Advant. The effect of solution environment on the stability and aggregation of recombinant human interleukin-2. Ph.D. Thesis, University of Connecticut, U.M.I. Publ., Ann Arbor (MI), USA, 1994, pp. 31–34.
F. Markwardt. The development of hirudin as an antithrombotic drug. Thromb. Res. 74(1):1–23 (1994).
H. Haruyama and K. Wüthrich. Conformation of recombinant desulfatohirudin in aqueous solution determined by nuclear magnetic resonance. Biochemistry 28:4301–4312 (1989).
K. Forrer, P. Girardot, M. Dettwiler, W. Märki, H. Grossenbacher, and E. Gassmann. Different modes of capillary electrophoresis for the analysis of recombinant hirudin. 9th International Symposium on Capillary Electrophoresis. Budapest, Hungary. 1994.
C. Dette and H. Wätzig. Separation of r-hirudin from similar substances by capillary electrophoresis. J. Chromatogr. A 700:89–94 (1995).
U. Gietz. Therapeutic protein formulation for sustained delivery: Formulation aspects and stability. Ph.D. Thesis, Department of Pharmacy ETH, Zürich, 1997.
S. Clarke. Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins. Int. J. Peptide Protein Res. 30:808–821 (1987).
A. A. Kossiakoff. Tertiary structure is a principal determinant to protein deamidation. Science 240:191–194 (1988).
C. Oliyai and R. T. Borchardt. Chemical pathways of peptide degradation. IV. Pathways, kinetics and mechanism of degradation of an aspartyl residue in a model hexapeptide. Pharm. Res. 10:95–102 (1993).
T. V. Brennan and St. Clarke. Spontaneous degradation of poly-peptides at aspartyl and asparaginyl residues: Effect of the solvent dielectric. Protein Sci. 2:331–338 (1993).
T. J. Ahern and A. M. Klibanov. The mechanism of irreversible enzyme inactivation at 100°C. Science 228:1280–1284 (1985).
R. Pearlman and T. A. Bewley. Stability and characterization of human growth hormone. In: Y. J. Wang and R. Pearlman (eds.), Stability and characterization of protein and peptide drugs, Plenum Press, New York, 1993, pp 1.
R. I. Senderoff, S. C. Wootton, A. M. Boctor, T. M. Chen, A. B. Giordani, T. N. Julian, and G. W. Radebaugh. Aqueous stability of human epidermal growth factor 1–48. Pharm. Res. 11(12):1712–1720 (1994).
A. Otto and R. Seckler. Characterization, stability and refolding of recombinant hirudin. Eur. J. Biochem. 202:67–73 (1991).
R. Khurana, A. T. Hate, U. Nath, and J. B. Udgaonkar. pH dependence of the stability of barstar to chemical and thermal denaturation. Protein Science 4:1133–1144 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gietz, U., Alder, R., Langguth, P. et al. Chemical Degradation Kinetics of Recombinant Hirudin (HVI) in Aqueous Solution: Effect of pH. Pharm Res 15, 1456–1462 (1998). https://doi.org/10.1023/A:1011918108849
Issue Date:
DOI: https://doi.org/10.1023/A:1011918108849